One of the main factors that can influence your response to semaglutide is the presence of comorbidities, such as a history of early onset severe obesity, endocrine disorders, or developmental delays
It also stresses that individual response varies with dosing, formulation, and duration of therapy, and that the provider's assessment remains the primary guide for any medication decision
Additional Safety Information Semaglutide (Wegovy, Ozempic ), tirzepatide (Zepbound), orforglipron (Foundayo), liraglutide (Saxenda) Contraindications Personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
In clinical trials, hair loss was reported in 4-5% of people using tirzepatide (Zepbound) compared to 1% on placebo
Marshall Silverman, MD, a board-certified internal medicine specialist with over two decades of experience in Charlotte, combines his clinical role with academic pursuits as a clinical associate professor at UNC-Chapel Hill
Whirl: C10-18 Triglycerides, Talc, Hydrogenated Vegetable Oil, Caprylic/Capric Triglyceride, Rhus Succedanea (Japan) Fruit Wax, Tocopherol, Ascorbyl Palmitate